English  |  正體中文  |  简体中文  |  总笔数 :0  
造访人次 :  52368093    在线人数 :  1003
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"lin chia chi"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 56-65 / 148 (共15页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
國立臺灣大學 2015 探討度冬大杓鷸族群在彰化灘地之分布 林家琪; Lin, Chia-Chi
國立臺灣大學 2015 Pathological stage after neoadjuvant chemoradiation and esophagectomy superiorly predicts survival in patients with esophageal squamous cell carcinoma Wang, Chia-Chun; Cheng, Jason Chia-Hsien; Tsai, Chiao-Ling; Lee, Jang-Ming; Huang, Pei-Ming; Lin, Chia-Chi; Hsu, Chih-Hung; Hsieh, Min-Shu; Chang, Yih-Leong; Hsu, Feng-Ming; 林家齊; 張逸良; 成佳憲; 王嘉檇; 徐志宏; 謝明書; 李章銘; 黃培銘; 蔡巧琳; 許峰銘
國立臺灣大學 2015 Postchemoradiotherapy (CRT) pathologic stage classified by American Joint Committee on Cancer (AJCC) staging system to predict prognosis of patients with locally advanced esophageal squamous cell carcinoma (ESCC) Guo, Jhe-Cyuan; Huang, Ta-Chen; Lin, Chia-Chi; Hsieh, Min-Shu; Chang, Chin-Hao; Lee, Jang-Ming; Cheng, Jason C.; Wang, Hsiu-Po; Yeh, Kun-Huei; Cheng, Ann-Lii; Hsu, Chih-Hung; 林家齊; 鄭安理; 黃大成; 徐志宏; 葉坤輝; 謝明書; 郭哲銓; 王秀伯; 張晉豪
國立臺灣大學 2015 Postchemoradiotherapy Pathologic Stage Classified by the American Joint Committee on the Cancer Staging System Predicts Prognosis of Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Guo, Jhe-Cyuan; Huang, Ta-Chen; Lin, Chia-Chi; Hsieh, Min-Shu; Chang, Chin-Hao; Huang, Pei-Ming; Lee, Jang-Ming; Hsu, Feng-Ming; Cheng, Jason Chia-Hsien; Wang, Hsiu-Po; Yeh, Kun-Huei; Cheng, Ann-Lii; Hsu, Chih-Hung; 林家齊; 鄭安理; 成佳憲; 黃大成; 徐志宏; 葉坤輝; 謝明書; 郭哲銓; 李章銘; 王秀伯; 黃培銘; 許峰銘; 張晉豪
國立臺灣大學 2015 Phase 1 study of the investigational Aurora A kinase inhibitor alisertib (MLN8237) in East Asian cancer patients: pharmacokinetics and recommended phase 2 dose Venkatakrishnan, Karthik; Kim, Tae Min; Lin, Chia-Chi; Thye, Lim Soon; Chng, Wee Joo; Ma, Brigette; Chen, Ming Huang; Zhou, Xiaofei; Liu, Hua; Kelly, Virginia; Kim, Won Seog; 林家齊
國立臺灣大學 2015 A randomized Phase 3 study comparing first-line pemetrexed plus cisplatin followed by gefitinib maintenance (PC/G) with gefitinib monotherapy (G) in East Asian patients (pts) with locally advanced or metastatic nonsquamous non-small cell lung cancer (nSqNSCLC): Final survival results. Yang, James Chih-Hsin; Srimuninnimit, Vichien; Ahn, Myung-Ju; Lin, Chia-Chi; Kim, Sang-We; Tsai, Chun-Ming; Mok, Tony; Orlando, Mauro; Puri, Tarun; Wang, Xin; Park, Keunchil; 林家齊; 楊志新
國立臺灣大學 2015 Epidermal growth factor receptor tyrosine kinase inhibitors on clinical outcome of advanced non-small cell lung cancer patients with leptomeningeal carcinomatosis. Liao, Bin-Chi; Lee, Jih-hsiang; Lin, Chia-Chi; Ho, Chao-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Yang, James Chih-Hsin; 林家齊; 楊志新; 廖斌志; 余忠仁; 何肇基; 施金元; 李日翔
國立臺灣大學 2015 Ipilimumab in treating Asian patient with advanced melanoma: The preliminary report of Taiwan ipilimumab extended access program group Wu, Chun-Feng; Huang, Wen Kuan; Liu, Jun-Huang; Lin, Chen-Yuan; Liu, Ta-Chih; Lin, Chia-Chi; Su, Wu-Chou; Yeh, Yumin; Cheng, Shih-Tsung; Lin, Sheng-Fung; Hong, Ruey-Long; Chang, John W. C.; 林家齊; 洪瑞隆
國立臺灣大學 2015 Second and third-generation epidermal growth factor receptor tyrosine kinase inhibitors in advanced nonsmall cell lung cancer Liao, Bin-Chi; Lin, Chia-Chi; Yang, James Chih-Hsin; 林家齊; 楊志新; 廖斌志
國立臺灣大學 2015 Treating patients with ALK-positive non-small cell lung cancer: latest evidence and management strategy Liao, Bin-Chi; Lin, Chia-Chi; Shih, Jin-Yuan; Yang, James Chih-Hsin; 林家齊; 楊志新; 廖斌志; 施金元

显示项目 56-65 / 148 (共15页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目